The Global Governance of Antibiotic Stewardship: A One Health Scoping Review and the Integrated Polycentric Glocal Governance Framework (IPGF)
DOI:
https://doi.org/10.35516/jmj.v59i5.4133الكلمات المفتاحية:
antimicrobial resistance، antibiotic stewardship، global health governance، One Health، polycentric governanceالملخص
Antimicrobial resistance (AMR) poses a serious and growing threat to global public health, undermining decades of progress in infectious disease control. Antibiotic stewardship (ABS) — aimed at optimizing antimicrobial use across human, animal, and environmental health — has become central to this response. This article presents a scoping review of 203 academic and grey literature sources to examine the global governance architecture of ABS. Anchored in a One Health lens and drawing on multi-level and polycentric governance theory, the review maps key actors, institutional arrangements, and policy mechanisms shaping international stewardship efforts. Despite growing consensus, stewardship governance remains fragmented, underfunded, and marked by stark disparities between high-income and low- and middle-income countries. To address these challenges, the paper proposes an original Integrated Polycentric Glocal Governance Framework (IPGF) and applies it to two case studies in the Middle East and North Africa (MENA) region. This model emphasizes decentralized coordination, stakeholder inclusivity, and adaptive learning to better align global norms with local realities. The findings call for structural reform and innovative governance approaches to strengthen global antibiotic stewardship and mitigate the accelerating AMR crisis.
المراجع
O’Neill J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Review on Antimicrobial Resistance; 2016.
World Bank. Drug-resistant infections: A threat to our economic future. Washington, DC: World Bank; 2017.
WHO. Global Action Plan on Antimicrobial Resistance. Geneva: World Health Organization; 2015.
Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet. 2016;387(10014):176–187.
Destoumieux-Garzón D, Mavingui P, Boetsch G, et al. The One Health Concept: 10 Years Old and a Long Road Ahead. Front Vet Sci. 2018;5:14.
WHO, FAO, WOAH, UNEP. One Health Joint Plan of Action (2022–2026). Geneva: Quadripartite Collaboration; 2022. Retrieved February 3, 2024, from https://www.who.int/publications/i/item/9789240059139.
Laxminarayan R, Van Boeckel T, Frost I, et al. The Lancet Infectious Diseases Commission on AMR. Lancet Infect Dis. 2020;20(4):e53–e109.
WHO. Global progress report on antimicrobial resistance: slow progress in addressing AMR. Geneva: WHO; 2021.
FAO, WOAH, UNEP, WHO. Quadripartite Monitoring Framework for AMR. 2023. Retrieved February 3, 2024, from https://www.qjsamr.org/technical-work/about.
Hooghe L, Marks G. Unraveling the central state, but how? Am Polit Sci Rev. 2003;97(2):233–243.
Bache I, Flinders M. Multi-level Governance. Oxford: Oxford University Press; 2004.
Rochford C, Sridhar D, Woods N, et al. Global governance of antimicrobial resistance. Lancet. 2018;391(10134):1976–1978.
Ostrom E. Beyond markets and states: polycentric governance. Am Econ Rev. 2010;100(3):641–672.
Sabatier PA, ed. Theories of the Policy Process. 3rd ed. Boulder, CO: Westview Press; 2007.
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.
WHO. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2021. Geneva: WHO; 2021.
Anderson M, et al. Global governance mechanisms to address antimicrobial resistance. Global Health. 2019;15(1):1–12.
Dar OA, et al. Exploring the evidence base for national and regional policy interventions to combat resistance. Lancet. 2016;387(10015):285–295.
G7 Global AMR R&D Hub. Dynamic Dashboard Report 2023. Berlin: G7 Secretariat; 2023.
Renwick MJ, Brogan DM, Mossialos E. A systematic review and critical assessment of incentive strategies for development of novel antibiotics. J Antibiot. 2016;69(2):73–88.
AMR Industry Alliance. 2021 Progress Report. Retrieved January 22, 2024 from: https://www.amrindustryalliance.org.
ReAct. Strategic Plan 2021–2025. Uppsala: ReAct; 2021.
Wernli D, Jørgensen PS, Morel CM, et al. Mapping global policy discourse on antimicrobial resistance. BMJ Glob Health. 2017;2(2):e000378.
G20 Health Working Group. 2022 G20 Tourism Ministrial Meeting Chair’s Summary. Retrieved January 13, 2024, from https://g20.utoronto.ca/2022/221028-health.html.
WHO. Country self-assessment survey on AMR 2021–2022. Geneva: WHO; 2022. Retrieved June 13, 2024, from
https://www.amrcountryprogress.org/.
Auta A, et al. Global access to antibiotics without prescription in community pharmacies. J Infect. 2019;78(1):8–18.
Holloway K, van Dijk L. The World Medicines Situation 2011 – Rational Use of Medicines. WHO; 2011.
Hoffman SJ, Røttingen JA. Assessing the expected impact of global governance instruments on AMR. Milbank Q. 2015;93(3):559–602.
Ledingham K, et al. Financing the fight against AMR: obstacles and opportunities. Center for Global Development; 2021.
WHO. Jordan Pilots Point Prevalence Surveys for Antimicrobial Use. Geneva: World Health Organization; 2023. Retrieved July 7, 2025 from https://www.who.int/news/item/30-03-2023-jordan-pilots-point-prevalence-surveys-for-antimicrobial-use
Farhat MR, Brothers C, Meyer A, et al. Building antimicrobial stewardship in low- and middle-income countries: The role of pharmacy-based interventions. Journal of Global Health Reports. 2022;6:e2022065.
Ministry of Health, Jordan. National Action Plan for Combating Antimicrobial Resistance in Jordan 2023–2025. Amman: Government of Jordan; 2023.
WHO Eastern Mediterranean Regional Office. Antimicrobial Resistance Country Self-Assessment: Egypt. Cairo: WHO EMRO; 2022.
Taha HA, Morsi TS, El Sherif F, et al. Implementation of Antimicrobial Stewardship Programs in Two Tertiary Hospitals in Jordan: Lessons Learned from a Collaborative Pilot Project. Antimicrobial Resistance & Infection Control. 2023;12(1):45.
El Mahalli A. WHO Global Strategy for Containment of Antimicrobial Resistance: Challenges and Implications for Egypt. Eastern Mediterranean Health Journal. 2021;27(4):403–410.
Abdel-Aziz M, Abozeid M, Salama M, et al. Policy Approaches to Antimicrobial Resistance in the Arab Middle East: Moving from Problem Recognition to Regional Action. Journal of Infection and Public Health. 2022;15(1):107–114.
